Osteopore invests in stem cell, aging research
Tissue regeneration developer Osteopore is to invest in a new entity, Regen SPV, to be setup by scientists Dr Xianmin Zeng and Dr Brian Kennedy. Regen SPV aims to advance cutting-edge regenerative technologies, disease cures, and the promotion of geroscience and longevity. Its work will continue to advance the broader understanding of aging and the…